These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 8356794

  • 1. Differences between cell membrane fusion activities of two dengue type-1 isolates reflect modifications of viral structure.
    Desprès P, Frenkiel MP, Deubel V.
    Virology; 1993 Sep; 196(1):209-19. PubMed ID: 8356794
    [Abstract] [Full Text] [Related]

  • 2. Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus.
    Duarte dos Santos CN, Frenkiel MP, Courageot MP, Rocha CF, Vazeille-Falcoz MC, Wien MW, Rey FA, Deubel V, Desprès P.
    Virology; 2000 Sep 01; 274(2):292-308. PubMed ID: 10964773
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites.
    Johnson AJ, Guirakhoo F, Roehrig JT.
    Virology; 1994 Sep 01; 203(2):241-9. PubMed ID: 8053148
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.
    Novotny MJ, Parish ML, Spear PG.
    Virology; 1996 Jul 01; 221(1):1-13. PubMed ID: 8661409
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP, Marchevsky RS, Liprandi F, Bonaldo MC, Coutinho ES, Dieudonné M, Caride E, Jabor AV, Freire MS, Galler R.
    Trans R Soc Trop Med Hyg; 2007 Mar 01; 101(3):289-98. PubMed ID: 17169387
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the steps involved in Dengue virus entry into host cells.
    Hung SL, Lee PL, Chen HW, Chen LK, Kao CL, King CC.
    Virology; 1999 Apr 25; 257(1):156-67. PubMed ID: 10208929
    [Abstract] [Full Text] [Related]

  • 19. Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion.
    Butrapet S, Childers T, Moss KJ, Erb SM, Luy BE, Calvert AE, Blair CD, Roehrig JT, Huang CY.
    Virology; 2011 Apr 25; 413(1):118-27. PubMed ID: 21353281
    [Abstract] [Full Text] [Related]

  • 20. Molecular epidemiological study of dengue virus type 1 in Taiwan.
    Hwang KP, Chu PY, Tung YC, Wang HL, Yueh YY, Wu YC, Chin C, Lin KH.
    J Med Virol; 2003 Jul 25; 70(3):404-9. PubMed ID: 12767004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.